İmdat Dılek
- Hematology top 5%
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 6
- Blood groups and transfusion 5
- Platelet Disorders and Treatments 4
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
-
- Eosinophilic Disorders and Syndromes 6
-
- Lymphoma Diagnosis and Treatment 5
İmdat Dılek
67 papers receiving 526 citations
Peers
Comparison fields: 5 of 88
- Hematology 214
- Genetics 82
- Nephrology 27
- Oncology 101
- Transplantation 9
Countries citing papers authored by İmdat Dılek
This map shows the geographic impact of İmdat Dılek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İmdat Dılek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İmdat Dılek more than expected).
Fields of papers citing papers by İmdat Dılek
This network shows the impact of papers produced by İmdat Dılek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İmdat Dılek. The network helps show where İmdat Dılek may publish in the future.
Co-authorship network
The 25 scholars most cited alongside İmdat Dılek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 6 | |
| 7 | Vitamin B12 Level Have Prognostic Significance in Multiple Myeloma Patients | 2018 | 1 |
| 8 | Occult urinary incontinence in elderly women and its association with geriatric condition. | 2016 | 15 |
| 9 | 2015 | 10 | |
| 10 | Combined factor V and factor VIII deficiency: the report of two cases | 2011 | 0 |
| 11 | 2010 | 17 | |
| 12 | Hematological Complications in 787 Cases of Acute Brucellosis in Eastern Turkey | 2008 | 18 |
| 13 | Atropa Belladonna İle Zehirlenme: Bir Olgu Sunumu | 2006 | 5 |
| 14 | 2006 | 15 | |
| 15 | Yılan ısırığı sonucu gelişen yaygın damar içi pıhtılaşması ve multi organ yetmezliği: İki olgu sunumu | 2005 | 1 |
| 16 | Reanimasyon ünitemizdeki erişkin zehirlenme olgularının incelenmesi | 2004 | 1 |
| 17 | 2001 | 11 | |
| 18 | 2000 | 10 | |
| 19 | 1999 | 28 | |
| 20 | 1999 | 7 |
About İmdat Dılek
İmdat Dılek is a scholar working on Hematology, Genetics, Rheumatology, Nephrology and Oncology, having authored 72 papers that have together received 553 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Blood groups and transfusion (5 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Hematology (214 citations), Genetics (82 citations), Nephrology (27 citations), Oncology (101 citations) and Transplantation (9 citations). İmdat Dılek has collaborated with scholars based in Türkiye, Kuwait and Iran. Frequent co-authors include Cengiz Demır, Ahmet Faik Öner, Ali Bay, Reha Erkoç, Şule Mine Bakanay, Muhıt Özcan, Hayriye Sayarlıoğlu, Serdar Uğraş, Mutlu Arat and Hakan Çankaya. Their work appears in journals such as Redox Report, Renal Failure, International Journal of Clinical Practice, Bone Marrow Transplantation and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.